Moody Aldrich Partners LLC Trims Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Moody Aldrich Partners LLC reduced its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 9.2% in the fourth quarter, Holdings Channel reports. The firm owned 66,866 shares of the company’s stock after selling 6,767 shares during the period. Moody Aldrich Partners LLC’s holdings in Axsome Therapeutics were worth $5,322,000 at the […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,United States ,Roger Jeffs ,Markl Jacobson ,Piper Sandler ,Blackrock Inc ,Nasdaq ,Vanguard Group Inc ,Axsome Therapeutics Inc ,Royal Bank ,Moody Aldrich Partners ,Citigroup ,Holdings Channel ,Cantor Fitzgerald ,Securities Exchange Commission ,Axsome Therapeutics ,Free Report ,Aldrich Partners ,State Street Corp ,Street Corp ,Director Roger Jeffs ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Axsome Therapeutics Daily ,Nasdaq Axsm ,Axsm ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,